Open AccessAntifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
Author(s) -
Margaret L. Salisbury,
Craig Conoscenti,
Daniel A. Culver,
Eric Yow,
Megan L. Neely,
Shaun Bender,
N Hartmann,
Scott M. Palmer,
Thomas B. Leonard,
Ipf-ProTM Registry investigators
Publication year - 2020
Publication title -
annals of the american thoracic society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 114
eISSN - 2329-6933
pISSN - 2325-6621
DOI - 10.1513/annalsats.201912-880oc
Subject(s) - medicine , idiopathic pulmonary fibrosis , nintedanib , pirfenidone , oxygen therapy , interstitial lung disease , vital capacity , diffusing capacity , lung , lung function